Related Experiment Videos
Use and misuse of a digoxin assay service
Insights
Digoxin assay requests often lack clear clinical indication or proper timing. Inappropriately timed samples can lead to incorrect treatment decisions, impacting patient care.
Area of Science:
- Clinical Chemistry
- Pharmacokinetics
- Therapeutic Drug Monitoring
Background:
- Digoxin assays are crucial for therapeutic drug monitoring.
- Accurate interpretation relies on appropriate clinical context and sample timing.
- Suboptimal use of digoxin assays can lead to clinical mismanagement.
Purpose of the Study:
- To audit digoxin assay requests and assess their influence on clinical management.
- To identify issues related to clinical indication and sample collection timing.
- To evaluate the impact of assay results on treatment decisions.
Main Methods:
- Retrospective audit of 285 digoxin assay requests over 12 weeks.
- Analysis of clinical indication for each request.
- Assessment of the time interval between last digoxin dose and blood sample collection.
- Review of changes in patient treatment following assay result receipt.
Main Results:
- 24% of requests lacked clear clinical indication.
- 50% of requests had unknown or inappropriate timing between last dose and sample collection.
- 22% of patients had treatment changes post-assay; 10% of these changes were unrelated to the initial indication.
- Samples drawn within 6 hours of the last dose were more likely to lead to treatment reduction (22%) compared to those drawn after 6 hours (9%).
Conclusions:
- A significant proportion of digoxin assay requests are inappropriate or lack proper timing.
- Incorrectly timed samples pose a risk for making unwarranted clinical decisions.
- Improved guidelines and education are needed for optimal use of digoxin assays in clinical practice.
Abstract:
In a study of the use of a digoxin assay service and its influence on clinical management 285 assay requests were audited over 12 weeks. For 67 (24%) there was no clear clinical indication for the request and for 140 the period between the last dose of digoxin being given and the blood sample being taken was either unknown or inappropriate. Treatment in 64 patients (22%) was changed after the assay result was received [corrected]. 24 of these changes bore no relation to the original clinical indication for requesting the assay, suggesting that such changes were based on the assay result alone. Of samples collected within six hours after the last dose, 15 of 69 (22%) led to a reduction in treatment compared with 10 of 116 (9%) taken after six hours (p less than 0.025), thereby highlighting the danger that incorrectly timed samples may lead to inappropriate clinical decisions.